ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV (levoketoconazole) for the Treatment of Cushing’s Syndrome
June 04, 2021SBBP today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 11,020,393 entitled, "Methods of Treating Disease with Levoketoconazole" which covers a method of treating Cushing's syndrome patients with RECORLEV® -
HRA Pharma Rare Diseases funds online hub for Cushing’s Syndrome
March 18, 2021HRA Pharma Rare Diseases, an affiliate of global consumer healthcare company HRA Pharma, has announced it is funding an online platform containing information and news on Cushing’s Syndrome.
Pharma Sources Insight January 2025
